Coming December: ASH publishes its late-breaking abstracts. We’ll add the organizations presenting them.

Memorial Sloan Kettering Cancer Center at ASH 2026

Dec 12–15, 2026 New Orleans, LA ~30k attendees Website

Memorial Sloan Kettering Cancer Center brings 123 presentations to ASH 2026 in New Orleans. Its program centres on leukemia and myeloma treatment alongside CAR T cell therapy and transplant. It also covers infections and clots after CAR T, how splicing mutations drive leukemia, and the first U.S. CAR-T trial in AL amyloidosis.

OrganizationASH 2026 Attendance
Hospitals & cancer centres
NCI-designated comprehensive cancer center in New York City combining cancer care, research and education.
Talk
Fri Dec 11
9:00am–12:00pm
Symposium
Fri Dec 11
11:00am–2:00pm
Best Practice Use of Bispecific Antibodies in Non-Hodgkin Lymphoma – A Second Opinion Case Review
Difficult non-Hodgkin lymphoma cases treated or considered for bispecific antibodies, with reviews of recent data, current practice, and ongoing trials.
Lymphoma · New drugs
Symposium
Fri Dec 11
11:00am–2:00pm
CLL Challenge! Interrogating the Latest Evidence on Patient Priorities and Novel Targeted Therapies
Shared decision-making in chronic lymphocytic leukemia, using biomarker testing to choose among fixed-duration, continuous, and newer targeted treatments.
Symposium hosted by Decera Clinical Education
Lymphoma
Symposium
Fri Dec 11
11:00am–2:00pm
CML Treatment Continuum: Optimizing Therapy Selection, Molecular Monitoring, And Long-Term Quality of Life
First-line drug choice, resistance, long-term side effects, and treatment-free remission in chronic myeloid leukemia, plus pipeline agents.
Leukemias
Symposium
Fri Dec 11
11:00am–2:00pm
Mastering Systemic Mastocytosis: Diagnostic Criteria, Risk Stratification, and Patient-Centered Treatment Across Indolent and Advanced Disease
Diagnosing systemic mastocytosis, separating indolent from advanced disease, preventing anaphylaxis, and choosing between symptom control and Kit-targeted drugs.
Symposium hosted by Decera Clinical Education
Leukemias
Symposium
Fri Dec 11
3:00pm–6:00pm
A Case-Based Exploration of Current and Future Directions in Myelofibrosis – Where We Are, Where We’re Going
Real patient cases showing how experts treat myelofibrosis today, paired with reviews of current data and ongoing research on emerging therapies.
Leukemias
Symposium
Fri Dec 11
3:00pm–6:00pm
Immune Therapy for Myeloma: From CAR T and T-Cell Engagers to Community Care
Sequencing CAR-T and T-cell engagers for relapsed myeloma, when to refer, managing toxicity, and options after B-cell maturation antigen therapy fails.
Myeloma · Cell & gene
Symposium
Fri Dec 11
3:00pm–6:00pm
Live Tumor Board: Advancing Clinical Competence in Primary CNS Lymphoma — Navigating Molecular Pathways and Emerging Therapies
Treating primary central nervous system lymphoma, from methotrexate-based induction and consolidation choices to new drugs aimed at its signaling mutations.
Lymphoma
Session
Fri Dec 11
3:00pm–5:28pm
Scientific Workshop on Interplay between Coagulation and Malignancy
Short research talks and discussion on why cancer patients develop blood clots, linking junior and established investigators in cancer and thrombosis.
Clotting
Session
Fri Dec 11
4:24pm–5:23pm
Coagulation and Cancer Progression
How clotting and clot-dissolving pathways shape tumor growth and immune responses, drawing on pancreatic cancer research.
Clotting
Talk
Sat Dec 12
4:00pm–5:35pm
Novel Uses of RNA as Therapeutics
Synthetic RNAs that exploit faulty splicing to kill cancer cells with splicing-factor mutations, and mRNA vaccines against mis-spliced protein fragments.
Blood biology · Leukemias
Session
Sun Dec 13
9:30am–10:45am
Designing Microbiome-Directed Interventional Trials in Hematologic Malignancies
How to design clinical trials that alter the gut microbiome in blood cancers, including fecal microbiota transplants to prevent graft-versus-host disease.
Blood biology
Talk
Sun Dec 13
9:30am–10:45am
Dietary and Prebiotic Intervention Strategies
Changing gut bacteria through diet and prebiotic fiber, the evidence linking food to patient outcomes, and how to design rigorous nutrition trials.
Blood biology
Talk
Sun Dec 13
9:30am–10:45am
Live Bacterial Therapeutic Intervention Strategies
Giving patients defined mixtures of live bacteria to reshape the gut and cut infections after a donor stem cell transplant.
Blood biology
Session
Sun Dec 13
9:30am–10:45am
Advancing Personalized Care in Classic Hodgkin Lymphoma
Tailoring classic Hodgkin lymphoma treatment to risk, response and circulating tumor DNA to cure with less toxicity, plus personalized follow-up care.
Lymphoma
Session
Sun Dec 13
9:30am–11:00am
From Real-World Evidence to Real-World Impact: Translating Multiple Myeloma Data into Clinical Practice
Case studies showing how real-world multiple myeloma data reveal treatment patterns, outcomes in underrepresented groups, and care gaps, along with their limits.
Myeloma · AI & data
Talk
Sun Dec 13
4:30pm–5:45pm
Immune Determinants of Infections after CAR T- Cell Therapy: A Framework for Prevention and Management
Infection risk after CAR-T cell therapy, traced from early immune damage to lasting antibody deficits, and how to prevent infections at each stage.
Cell & gene
Session
Sun Dec 13
4:30pm–6:00pm
The AI Colleague: Promise, Peril, and Practice in Hematology
Where generative AI already helps hematology clinicians and researchers, where it can go wrong, and the safeguards it needs.
AI & data
Talk
Mon Dec 14
10:30am–11:45am
Acute Lymphoblastic Leukemia in Adolescents and Young Adults: Improving Outcomes Beyond the Use of Two Pediatric Regimens
Raising cure rates for teens and young adults with acute lymphoblastic leukemia by adding immunotherapy to pediatric-style regimens and limiting lasting harm.
Leukemias
Talk
Mon Dec 14
2:45pm–4:00pm
Bispecific Antibodies and Cellular Therapies for Diffuse Large B-Cell Lymphoma
CAR-T cells and bispecific antibodies for diffuse large B-cell lymphoma, covering efficacy, side effects, patient selection, sequencing, and drugs in development.
Lymphoma

Explore the full ASH 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full ASH 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Memorial Sloan Kettering Cancer Center

Tell us what you sell and we’ll find the people at Memorial Sloan Kettering Cancer Center most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction